Abdulkader Rahmo
President & CSO SMSbiotech
Seminars
Thursday 17th September 2026
Regenerative Therapeutics for COPD: Mechanistic Approaches to Tissue Repair & Clinical Translation
1:30 pm
- Accelerating clinical impact through mucus clearance exploring strategies to target mucus obstruction as a reversible driver of airflow limitation, enabling faster demonstration of clinical benefit compared with interventions aimed at reversing structural lung damage
- Leveraging cell therapy for lung regeneration, utilizing nebulized cell-based interventions to modulate gene activity, reconstruct extracellular matrix, and restore lung tissue integrity
- Develop mechanistic biomarkers and integrate expanded access data to enhance dose selection, monitor early efficacy, and de-risk clinical trial design
